One-Year Outcomes of a Treat-and-Extend Regimen of Aflibercept for Exudative Age-Related Macular Degeneration.
2017
Purpose: The aim of this study was to investigate the 1-year outcomes of treat-and-extend aflibercept for exudative age-related macular degeneration (AMD) in Japa
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
15
Citations
NaN
KQI